CFO Karleen Oberton Sells 14,940 Shares of Hologic Inc

On January 29, 2024, Karleen Oberton, the Chief Financial Officer of Hologic Inc (NASDAQ: HOLX), executed a sale of 14,940 shares of the company, as disclosed in a recent filing with the Securities and Exchange Commission (SEC).

At the time of the insider transaction, Hologic Inc.’s shares were trading at $75, resulting in a market capitalization of $17.59 billion. The stock’s price-earnings ratio stands at 40.95, surpassing both the industry median of 27.56 and the company’s historical median price-earnings ratio.

Hologic Inc. is a leading medical technology firm specializing in the development, manufacturing, and supply of medical products for women’s health and well-being.

Over the past year, this insider has consistently sold a total of 14,940 shares and has not made any purchases of the company’s stock. The insider transaction history at Hologic Inc. reveals a consistent pattern of 0 insider buys and 8 insider sells over the same period.

Have you read?
Biggest banks in the world, as measured by total assets, 2023.
Highest-paid CEOs among Russell 3000 companies, 2023.
These Are the highest-paid CEOs among S&P 500 companies, 2023.
Ranked: The 50 Richest Celebrity Couples in the World, 2023.
The world’s wealthiest 300 cities, 2023.
Global Happiness Index: Happiest Countries In The World In 2023.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name